Related Experiment Video

Updated: Jun 23, 2026

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
04:56

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Published on: August 4, 2023

Impact of preinjury anticoagulation in patients with traumatic brain injury

Nasim Ahmed1, Christie Bialowas, Yen-Hong Kuo

  • 1Department of Surgery, Division of Trauma and Surgical Critical Care, Jersey Shore University Medical Center, 1945 State Route 33, Neptune, NJ 07754, USA. nahmed@meridianhealth.com

Southern Medical Journal
|April 18, 2009
PubMed

Insights

Pre-existing anticoagulation and antiplatelet use did not significantly alter outcomes in patients with head injuries. This study found no major differences in mortality or hospital stay for patients on these medications.

Area of Science:

  • Neurotraumatology
  • Pharmacology
  • Clinical Medicine

Background:

  • Head injuries pose significant clinical challenges.
  • Anticoagulation and antiplatelet agents are commonly used for various medical conditions.
  • The impact of these medications on head injury outcomes requires thorough investigation.

Purpose of the Study:

  • To evaluate the effect of pre-existing anticoagulation and antiplatelet therapy on the outcomes of patients with traumatic brain injuries.
  • To compare outcomes between head injury patients on different anticoagulation/antiplatelet agents and those not on these medications.

Main Methods:

  • Retrospective analysis of medical records and trauma registry data.
  • Inclusion of adult trauma patients with CT-confirmed brain injuries on aspirin, clopidogrel bisulfate (Plavix), warfarin (Coumadin), or heparin.
  • Classification of patients into medication-based groups and a control group.

Main Results:

  • 29 patients on anticoagulation/antiplatelet agents and 63 controls were analyzed.
  • No significant differences observed in age, gender, Glasgow Coma Scale, or Injury Severity Score.
  • Mortality, ventilator days, ICU days, hospital days, and discharge disposition showed no significant variations among groups.

Conclusions:

  • Pre-injury use of anticoagulation or antiplatelet agents did not significantly impact patient outcomes following head injury.
  • Findings suggest that common anticoagulation and antiplatelet therapies may not adversely affect outcomes in this patient population.
Abstract

More Related Videos

Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury07:21

Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury

Published on: May 27, 2022

Related Concept Videos

Traumatic Brain Injury l: Introduction01:28

Traumatic Brain Injury l: Introduction

DefinitionTraumatic brain injury, or TBI, is a disturbance of normal brain function induced by an external mechanical force, such as a direct blow to the head or a penetrating injury. It can affect both brain structure and function, producing a wide range of clinical outcomes. TBI is a heterogeneous condition, meaning its effects may differ based on the type, location, and severity of the injury.Basis of ClassificationTBI is classified based on severity, injury mechanism, or pathophysiology. In...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...